AI Therapists vs Insight

AI Therapists - Mental Health Chatbots offer 24/7 access to advanced AI-powered therapists and psychologists. With round-the-clock availability, these chatbots provide accessible and confidential mental health support, empowering individuals to seek help whenever they need it. Each AI therapist can communicate in all languages, ensuring no language barriers exist for users seeking assistance.

Strong data protection and privacy policies are in place, ensuring that conversations remain private and secure. The AI chatbots provide objective, non-judgmental responses, fostering a safe and supportive environment for users. Users have full control to start and stop sessions at their convenience without any pressure for long sessions.

These AI chatbots maintain consistent performance and do not experience turnover, unlike human therapists who might retire or become unavailable. This ensures continuous availability and reliability in mental health support, aiding users in reframing negative thoughts and improving their mental health.

Insight is a medical research platform that helps scientists move from a research question to literature-backed summaries, hypotheses, and structured experiment plans. You define a medical research objective, and the platform runs tasks against peer-reviewed biomedical databases to build cited outputs. It is free to try, with optional registration to save objectives on a personal dashboard.

The workflow centers on iterative research cycles. After you submit an objective, Insight outlines a plan in its Thoughts output, then executes tasks against integrated sources including PubMed, NIH RePORTER, ClinicalTrials.gov, MyGene, and MyVariant. Each completed cycle refines the plan and deepens the scientific summary, hypotheses, and citations tied to your question.

Insight Research is available now for literature review, hypothesis generation, and experimental design drafting. Insight Discovery, a separate high-throughput module for target and biomarker identification, remains waitlist-only. The platform is built for researchers in drug discovery, clinical research, and genetics who want structured assistance without manually searching across separate NIH and genomic databases.

Founded in August 2023, Insight positions itself as an accessible research studio for medical scientists. The team publishes documentation, offers email and Discord support, and integrates data sources spanning more than 36 million PubMed articles, 22 million genes, and 400 million human variants.